Sonendo Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Sonendo şirketinin toplam hissedar öz sermayesi $17.9M ve toplam borcu $19.3M olup, bu da borç-öz sermaye oranını 108.1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $46.3M ve $28.4M dir.

Anahtar bilgiler

108.1%

Borç/özkaynak oranı

US$19.31m

Borç

Faiz karşılama oranı	n/a
Nakit	US$24.24m
Eşitlik	US$17.87m
Toplam yükümlülükler	US$28.43m
Toplam varlıklar	US$46.30m

Son finansal sağlık güncellemeleri

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: SONX 'nin kısa vadeli varlıkları ( $42.5M ) kısa vadeli yükümlülüklerini ( $17.7M ) aşıyor.

Uzun Vadeli Yükümlülükler: SONX şirketinin kısa vadeli varlıkları ( $42.5M ) uzun vadeli yükümlülüklerini ( $10.7M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: SONX şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: SONX şirketinin borç/öz sermaye oranının son 5 yılda azalıp azalmadığını belirlemek için yeterli veri yok.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: SONX şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: SONX serbest nakit akışı her yıl % 1.2 2.1 yıl yetecek nakit akışına sahip olacaktır.

Sonendo Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

NYSE Intends to Apply to SEC for Delisting of the Sonendo's Common Stock

Sonendo Announces Suspension of NYSE Trading, to Commence Trading on the OTCQX Effective November 22, 2023

Sonendo, Inc. Announces Receipt of Notice of Non-Compliance with NYSE Trading Share Price Listing Rule

Recent updates

Sonendo, Inc. Launches ProControl for the G4 System

Sonendo, Inc. Revises Guidance for the Fiscal Year 2024

Sonendo, Inc. Announces Impairment of Long-Lived Assets for the Three Months Ended June 30, 2024

Sonendo, Inc. to Report Q2, 2024 Results on Aug 07, 2024

Sonendo, Inc. Announces the Appointment of John Bostjancic as Chief Financial Officer

Sonendo, Inc. Raises Revenue Guidance for the Full Year of 2024

Sonendo, Inc., Annual General Meeting, Jun 10, 2024

Sonendo, Inc. to Report Q1, 2024 Results on May 08, 2024

NYSE Intends to Apply to SEC for Delisting of the Sonendo's Common Stock

Sonendo, Inc. Announces Impairment of Long-Lived Assets for the Three Months Ended December 31, 2023

Sonendo, Inc. Announces Impairment of Long-Lived Assets for the Three Months Ended December 31, 2023

Sonendo, Inc. Announces CFO Changes

Sonendo, Inc. Announces CFO Changes

Valsoft Corporation Inc. acquired Dog Breath Software, Inc. from Sonendo, Inc. (OTCPK:SONX) for approximately $16 million.

Valsoft Corporation Inc. acquired Dog Breath Software, Inc. from Sonendo, Inc. (OTCPK:SONX) for approximately $16 million.

Sonendo, Inc. to Report Fiscal Year 2023 Results on Mar 11, 2024

Sonendo, Inc. Announces Resignation of Karen Mcginnis as Director and Member of the Audit Committee and Compensation Committee, Effective March 31, 2024

Sonendo Announces Suspension of NYSE Trading, to Commence Trading on the OTCQX Effective November 22, 2023

Sonendo, Inc. Announces Resignation of Michael Smith as Chief Commercial Officer Effective December 1, 2023

Price target decreased by 14% to US$1.67

Analysts Have Just Cut Their Sonendo, Inc. (NYSE:SONX) Revenue Estimates By 18%

Third quarter 2023 earnings: EPS misses analyst expectations

Sonendo, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Sonendo, Inc. Provides Revenue Guidance for the Third Quarter and Full Year 2023

Sonendo, Inc. Announces Receipt of Notice of Non-Compliance with NYSE Trading Share Price Listing Rule

Sonendo, Inc. Announces Launch of Second Generation CleanFlow Procedure Instrument for Heightened Efficacy and Ease of Use

Price target decreased by 15% to US$2.65

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Sonendo, Inc. Provides Revenue Guidance for the Third Quarter and Full Year of 2023

Sonendo, Inc.'s Enhanced CleanFlow Procedure Instrument Now Indicated for Use on Anterior Teeth

Price target decreased by 7.5% to US$3.10

Sonendo, Inc. Announces the Publication of New Study That Found the GentleWave System to Be Significantly More Effective Than Conventional Irrigation Methods at Dissolving TissueDissolution During Root Canal Procedures

New minor risk - Insider selling

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Sonendo, Inc. Provides Revenue Guidance for the Second Quarter and Full Year of 2023

A Piece Of The Puzzle Missing From Sonendo, Inc.'s (NYSE:SONX) Share Price

Insider recently bought US$80k worth of stock

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Sonendo, Inc. to Report Q4, 2022 Results on Mar 08, 2023

Sonendo unit PIPStek files patent infringement lawsuit against Biolase

Insider recently bought US$56k worth of stock

Price target decreased to US$3.67

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Sonendo, Inc. Provides Revenue Guidance for the Year 2022

GAAP EPS of -$0.47 misses by $0.08, revenue of $9.8M beats by $0.49M

Sonendo Announces Health Canada Regulatory Approval for Next Generation GentleWave G4 System

Sonendo, Inc. to Report Q3, 2022 Results on Nov 09, 2022

Sonendo® Announces Release of GentleWave® G4 System

Consensus forecasts updated

Sonendo, Inc. announced that it has received $62.999997 million in funding from ArrowMark Colorado Holdings, LLC

Sonendo, Inc. announced that it expects to receive $62.999997 million in funding from ArrowMark Colorado Holdings, LLC

Sonendo announces $63 million private placement

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Sonendo, Inc. Expects Revenue Guidance for Full Year 2022

Sonendo, Inc. to Report Q2, 2022 Results on Aug 10, 2022

President recently bought US$64k worth of stock

Sonendo, Inc. Announces Executive Management Team Changes

Insider recently bought US$133k worth of stock

Sonendo, Inc. Provides Revenue Guidance for the Year 2022

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Sonendo Announces Launch of Cleanflow™ Technology to Improve Doctor and Patient Experience

Sonendo, Inc. to Report Q1, 2022 Results on May 10, 2022

Cory A. Eaves and Paul S. Madera Not to Stand for Re-Election as Directors of Sonendo, Inc

Sonendo, Inc. to Report Q4, 2021 Results on Mar 23, 2022

Sonendo, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2021

Third quarter 2021 earnings: EPS and revenues exceed analyst expectations

Sonendo: Painful Debut For This Dental Play

Less than half of directors are independent

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi